News and Publications

Categories

WEBPORTAL

  • Hemoglobinopathies and β-Thalassemia: Investigating High-Res Mass Spectrometry

    Publications , Diagnostics February 18, 2020

    Early diagnosis of hemoglobin disorders and Thalassemias are become more important due to a high carrier frequency and ease of global migration. In a prospective… Read more

  • SSIEM 2019 in Rotterdam

    ARCHIMEDlife News August 27, 2019
    Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time presenting at SSIEM, 3 – 6… Read more

  • New cut-offs for lysosomal enzyme activities.

    ARCHIMEDlife News June 6, 2019
    We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal enzyme activities from Dried Blood Spots… Read more

  • Improving our ability to diagnose Hemoglobinopathies.

    ARCHIMEDlife News October 1, 2018

    Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University Medical Center Hamburg in Eppendorf Germany,… Read more

  • First LEA assay launched

    ARCHIMEDlife News March 14, 2018
    LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses (MPS) can be diagnosed from one… Read more

  • Awarded work: Hemoglobinopathies and Thalassemias

    Publications , Research & Developement March 14, 2018
    Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now starting into a prospective study in… Read more